Literature DB >> 12522071

Acetylcholine-induced vasodilation may depend entirely upon NO in the femoral artery of young piglets.

Ragnhild Støen1, Kristin Lossius, Jan Olof G Karlsson.   

Abstract

1 To characterize agonist-induced relaxation in femoral artery rings from young piglets, we compared the effect of a NOS-inhibitor N(omega)-nitro-L-arginine (L-NOARG), an NO-inactivator oxyhaemoglobin (HbO) and a soluble guanyl cyclase(sGC)-inhibitor 1H-[1,2,4]Oxadiazolo-[4,3,-alpha]quinoxalin-1-one (ODQ) on acetylcholine(ACh)-induced relaxation. The involvement of K(+) channel activation was studied on relaxations induced by ACh, the two NO donors sodium nitroprusside (SNP) and diethylamine (DEA) NONOate, and the cell membrane permeable guanosine 3'5' cyclic monophosphate (cGMP) analogue 8-Br-cGMP. 2 Full reversal of phenylephrine-mediated precontraction was induced by ACh (1 nM-1 microM) (pD(2) 8.2+/-0.01 and R(max) 98.7+/-0.3%). L-NOARG (100 microM) partly inhibited relaxation (pD(2) 7.4+/-0.02 and R(max) 49.6+/-0.8%). The L-NOARG/indomethacin(IM)-resistant response displayed characteristics typical for endothelium-derived hyperpolarizing factor (EDHF), being sensitive to a combination of the K(+) channel blockers charybdotoxin (CTX) (0.1 microM) and apamin (0.3 microM). 3 ODQ (10 microM) abolished relaxations induced by ACh and SNP. L-NOARG/IM-resistant relaxations to ACh were abolished by HbO (20 microM). 4 Ouabain (1 microM) significantly inhibited ACh-induced L-NOARG/IM-resistant relaxations and relaxations induced by SNP (10 microM) and 8-Br-cGMP (0.1 mM). A combination of ouabain and Ba(2+) (30 microM) almost abolished L-NOARG/IM-resistant ACh-induced relaxation (R(max) 7.7+/-2.5% vs 23.4+/-6.4%, with and without Ba(2+), respectively, P<0.05). 5 The present study demonstrates that in femoral artery rings from young piglets, despite an L-NOARG/IM-resistant component sensitive to K(+) channel blockade with CTX and apamin, ACh-induced relaxation is abolished by sGC-inhibition or a combination of L-NOARG and HbO. These findings suggest that relaxation can be fully explained by the NO/cGMP pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522071      PMCID: PMC1573628          DOI: 10.1038/sj.bjp.0705001

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  39 in total

1.  Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.

Authors:  L J Ignarro; G M Buga; K S Wood; R E Byrns; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation.

Authors:  J E Brayden
Journal:  Am J Physiol       Date:  1990-09

3.  Increased susceptibility of newborn puppy mesenteric arteries to ouabain and reduced extracellular K+ concentration.

Authors:  S Hayashi; M K Park
Journal:  Arch Int Pharmacodyn Ther       Date:  1987-08

4.  Effect of sodium-potassium pump inhibitors and membrane-depolarizing agents on sodium nitroprusside-induced relaxation and cyclic guanosine monophosphate accumulation in rat aorta.

Authors:  R M Rapoport; K Schwartz; F Murad
Journal:  Circ Res       Date:  1985-07       Impact factor: 17.367

5.  Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall.

Authors:  T L Little; J Xia; B R Duling
Journal:  Circ Res       Date:  1995-03       Impact factor: 17.367

6.  Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle.

Authors:  K Komori; R R Lorenz; P M Vanhoutte
Journal:  Am J Physiol       Date:  1988-07

7.  Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels.

Authors:  G Chen; H Suzuki; A H Weston
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

8.  Hyperpolarization and relaxation of arterial smooth muscle caused by nitric oxide derived from the endothelium.

Authors:  M Tare; H C Parkington; H A Coleman; T O Neild; G J Dusting
Journal:  Nature       Date:  1990-07-05       Impact factor: 49.962

9.  Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

Authors:  V M Bolotina; S Najibi; J J Palacino; P J Pagano; R A Cohen
Journal:  Nature       Date:  1994-04-28       Impact factor: 49.962

10.  Effect of ouabain and alterations in potassium concentration on relaxation induced by sodium nitroprusside.

Authors:  R M Rapoport; F Murad
Journal:  Blood Vessels       Date:  1983
View more
  6 in total

1.  Evaluation of bioavailability of nitric oxide in coronary circulation by direct measurement of plasma nitric oxide concentration.

Authors:  Yoji Neishi; Seiichi Mochizuki; Takehiro Miyasaka; Takahiro Kawamoto; Teruyoshi Kume; Renan Sukmawan; Miwako Tsukiji; Yasuo Ogasawara; Fumihiko Kajiya; Takashi Akasaka; Kiyoshi Yoshida; Masami Goto
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-28       Impact factor: 11.205

2.  Nitric oxide and prostaglandin inhibition during acetylcholine-mediated cutaneous vasodilation in humans.

Authors:  Marvin S Medow; June L Glover; Julian M Stewart
Journal:  Microcirculation       Date:  2008-08       Impact factor: 2.628

3.  Noninvasive measure of microvascular nitric oxide function in humans using very low-frequency cutaneous laser Doppler flow spectra.

Authors:  Julian M Stewart; Indu Taneja; Michael S Goligorsky; Marvin S Medow
Journal:  Microcirculation       Date:  2007 Apr-May       Impact factor: 2.628

4.  Developmental changes in myoendothelial gap junction mediated vasodilator activity in the rat saphenous artery.

Authors:  Shaun L Sandow; Kenichi Goto; Nicole M Rummery; Caryl E Hill
Journal:  J Physiol       Date:  2004-02-06       Impact factor: 5.182

5.  Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.

Authors:  Xavier Norel; Laurence Walch; Jean-Pierre Gascard; Vincent deMontpreville; Charles Brink
Journal:  Br J Pharmacol       Date:  2004-06-01       Impact factor: 8.739

6.  Combination of Ca2+ -activated K+ channel blockers inhibits acetylcholine-evoked nitric oxide release in rat superior mesenteric artery.

Authors:  E Stankevicius; V Lopez-Valverde; L Rivera; A D Hughes; M J Mulvany; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2006-09-11       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.